Edgen Stock·Dec 15 2025, 18:17Back
Amphastar Generic Approval Challenges Eli Lilly Forteo
Edgen Stock·Dec 15 2025, 18:17
[1] Eli Lilly Stock (LLY) News, Forecasts and Analyst Outlook — Retatrutide Breakthrough, Orforglipron FDA Timeline, and a $6B Manufacturing Bet (Dec. 14, 2025) - ts2.tech (https://ts2.tech/en/eli-lilly-stock-lly-news- ...)[2] Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas - Yahoo (https://www.yahoo.com/news/articles/atorvasta ...)[3] Vaxxas Secures TGA Licence to Manufacture Therapeutic Goods - markets.businessinsider.com (https://markets.businessinsider.com/news/stoc ...)
